US Walks Back Efficacy Claims About AstraZeneca’s COVID-19 Vaccine, Citing Cherry-Picked Data
Dimensions of Dental Hygiene
MARCH 23, 2021
Just after midnight on March 23, the United States National Institute of Allergy and Infectious Diseases announced that the independent review board overseeing AstraZeneca’s large-scale clinical trial had expressed concerns regarding the results, which demonstrated the company’s vaccine was highly effective at preventing COVID-19 illness.
98 
Let's personalize your content